
  
    
      
        Introduction_NNP
        Cystic_NNP fibrosis_NNS (_( CF_NNP )_) is_VBZ a_DT generalized_JJ exocrine_NN disease_NN
        resulting_VBG from_IN the_DT defective_JJ regulation_NN of_IN epithelial_NN
        chloride_NN ion_NN transport_NN within_IN various_JJ organ_NN systems_NNS ,_, most_RBS
        importantly_RB the_DT lungs_NNS [_NN 1_CD 2_CD 3_CD 4_CD ]_NN ._. This_DT dysfunction_NN can_MD
        arise_VB from_IN a_DT variety_NN of_IN mutations_NNS within_IN the_DT cystic_JJ
        fibrosis_NNS transmembrane_NN conductance_NN regulator_NN (_( CFTR_NNP )_) gene_NN on_IN
        chromosome_NN 7_CD ,_, which_WDT encodes_NNS the_DT transmembrane_NN pump_NN
        responsible_JJ for_IN regulating_VBG transepithelial_NN ion_NN levels_NNS [_NN 1_CD 2_CD
        4_CD ]_NN ._. This_DT defect_NN is_VBZ associated_VBN with_IN an_DT increased_VBN viscosity_NN
        of_IN the_DT airway_NN surface_NN fluid_JJ ,_, and_CC according_VBG to_TO some_DT studies_NNS ,_,
        an_DT altered_VBN salt_NN concentration_NN [_NN 5_CD 6_CD ]_NN ._. These_DT and_CC other_JJ
        pleiotropic_JJ effects_NNS of_IN the_DT CF_NNP gene_NN abnormality_NN increase_NN the_DT
        susceptibility_NN of_IN CF_NNP patients_NNS to_TO bronchopulmonary_JJ bacterial_JJ
        infection_NN by_IN opportunistic_JJ pathogens_NNS ._.
        
        Pseudomonas_NNP aeruginosa_NN is_VBZ the_DT most_RBS
        common_JJ pathogen_NN recovered_VBD from_IN the_DT lungs_NNS of_IN CF_NNP patients_NNS [_NN 2_CD
        3_CD ]_NN ._. This_DT predisposition_NN to_TO 
        P_NN ._. aeruginosa_NN infection_NN has_VBZ been_VBN
        attributed_VBN to_TO several_JJ factors_NNS ._. For_IN example_NN ,_, an_DT increase_NN in_IN
        asialo-_NN GM_NNP 
        1_CD glycoproteins_NNS on_IN the_DT apical_JJ surface_NN of_IN
        CF_NNP airway_NN epithelial_NN cells_NNS provides_VBZ greater_JJR opportunity_NN for_IN
        adhesion_NN by_IN the_DT type_NN IV_NNP pili_NN of_IN 
        P_NN ._. aeruginosa_NN [_NN 3_CD 7_CD 8_CD ]_NN ._.
        Furthermore_RB ,_, the_DT first_JJ extracellular_NN domain_NN of_IN wild_JJ type_NN
        CFTR_NNP has_VBZ been_VBN found_VBN to_TO act_VB as_IN a_DT 
        P_NN ._. aeruginosa_NN -_: specific_JJ receptor_NN ,_,
        which_WDT is_VBZ involved_VBN in_IN the_DT clearance_NN of_IN 
        P_NN ._. aeruginosa_NN from_IN the_DT airways_NNS via_IN
        epithelial_NN cell_NN desquamation_NN [_NN 9_CD 10_CD 11_CD ]_NN ,_, a_DT process_NN
        greatly_RB impaired_VBN in_IN the_DT CF_NNP lung_NN ._. Other_JJ conditions_NNS that_WDT abet_NN
        colonization_NN of_IN the_DT CF_NNP lung_NN include_VBP impairment_NN of_IN the_DT
        "_'' mucociliary_JJ escalator_NN "_'' and_CC macrophage-mediated_JJ
        phagocytosis_NNS by_IN the_DT viscous_JJ airway_NN secretions_NNS ._. If_IN elevated_JJ
        salt_NN concentrations_NNS exist_VBP within_IN these_DT secretions_NNS [_NN 5_CD 6_CD ]_NN ,_,
        they_PRP would_MD inhibit_VB α_NN and_CC β-defensins_JJ ,_, endogenous_JJ
        antibacterial_NN peptides_NNS produced_VBN by_IN neutrophils_NNS and_CC airway_NN
        epithelia_NN ,_, respectively_RB [_NN 2_CD 3_CD 12_CD 13_CD 14_CD 15_CD ]_NN ._. This_DT last_JJ
        point_NN is_VBZ still_RB under_IN review_NN as_IN recent_JJ evidence_NN suggests_VBZ
        that_IN CF_NNP airway_NN surface_NN fluid_NN may_MD be_VB isotonic_JJ not_RB hypertonic_JJ
        [_NN 16_CD ]_NN ._.
        In_IN recent_JJ years_NNS 
        Burkholderia_NNP cepacia_NN has_VBZ become_VBN the_DT
        second_JJ leading_VBG cause_NN of_IN death_NN in_IN patients_NNS with_IN chronic_JJ
        granulomatous_JJ disease_NN (_( CGD_NNP )_) ._. The_DT phagocytes_NNS of_IN such_JJ
        patients_NNS are_VBP deficient_NN in_IN their_PRP$ capacity_NN to_TO kill_VB organisms_NNS
        by_IN oxidative_JJ means_NNS because_IN of_IN a_DT defective_JJ NADPH_NNP oxidase_NN [_NN
        17_CD 18_CD ]_NN ._. 
        B_NNP ._. cepacia_NN also_RB poses_VBZ a_DT threat_NN to_TO
        patients_NNS with_IN CF_NNP ,_, either_CC cocolonizing_VBG those_DT already_RB
        infected_VBN with_IN 
        P_NN ._. aeruginosa_NN or_CC as_IN the_DT sole_JJ
        infecting_VBG agent_NN [_NN 2_CD 18_CD ]_NN ._. Although_IN rates_NNS of_IN colonization_NN
        can_MD vary_VB widely_RB (_( between_IN 5_CD and_CC 70_CD %_NN )_) ,_, 
        B_NNP ._. cepacia_NN is_VBZ isolated_VBN from_IN sputum_NN in_IN
        only_RB 10_CD %_NN -_: 20_CD %_NN of_IN patients_NNS with_IN CF_NNP [_NN 2_CD 3_CD ]_NN ._. 
        B_NNP ._. cepacia_NN ,_, a_DT very_RB diverse_JJ species_NNS ,_,
        has_VBZ been_VBN divided_VBN into_IN several_JJ "_'' classes_NNS "_'' of_IN bacteria_NNS ,_, i_NNP ._. e_SYM ._. ,_,
        genomovars_NNS ,_, collectively_RB referred_VBD to_TO as_IN the_DT 
        B_NNP ._. cepacia_NN complex_JJ ._. Genomovar_NNP III_NNP is_VBZ
        the_DT most_RBS common_JJ 
        B_NNP ._. cepacia_NN genomovar_NN isolated_VBN from_IN CF_NNP
        patients_NNS ,_, accounting_NN for_IN approximately_RB 80_CD %_NN of_IN 
        B_NNP ._. cepacia_NN isolates_VBZ in_IN CF_NNP patients_NNS ._.
        Genomovars_NNP II_NNP and_CC V_NNP have_VBP also_RB been_VBN recovered_VBN from_IN CF_NNP
        patients_NNS [_NN 18_CD ]_NN ._. Of_IN critical_JJ concern_NN are_VBP 
        B_NNP ._. cepacia_NN 's_POS transmissibility_NN from_IN
        one_CD patient_NN to_TO another_DT and_CC its_PRP$ propensity_NN to_TO give_VB rise_NN to_TO
        the_DT 
        B_NNP ._. cepacia_NN syndrome_NN ,_, which_WDT results_VBZ in_IN
        a_DT rapid_JJ decline_NN in_IN pulmonary_JJ function_NN [_NN 2_CD 18_CD ]_NN ._. The_DT
        ability_NN of_IN 
        B_NNP ._. cepacia_NN as_RB well_RB as_IN 
        P_NN ._. aeruginosa_NN to_TO cause_VB chronic_JJ
        bronchopulmonary_JJ infections_NNS in_IN CF_NNP patients_NNS is_VBZ exacerbated_VBN
        by_IN their_PRP$ intrinsic_JJ or_CC acquired_VBN resistance_NN to_TO many_JJ
        conventional_JJ antibiotics_NNS ._. Peptide_NNP antibiotics_NNS ,_, including_VBG
        protegrins_NNS ,_, are_VBP currently_RB under_IN consideration_NN as_IN novel_NN
        agents_NNS for_IN treating_VBG pulmonary_JJ infections_NNS in_IN CF_NNP
        patients_NNS ._.
        Antimicrobial_NNP peptides_NNS are_VBP synthesized_JJ either_CC
        nonribosomally_RB or_CC ribosomally_RB [_NN 19_CD ]_NN ._. Protegrin-_NNP 1_CD (_( PG-_NNP 1_LS )_) ,_,
        a_DT 2_CD kDa_NN cationic_JJ octadecapeptide_NN (_( RGGRLCYCRRRFCVCVGR-amide_NNP )_)
        was_VBD originally_RB isolated_VBN from_IN porcine_NN leukocytes_NNS [_NN 20_CD ]_NN and_CC
        falls_VBZ into_IN the_DT latter_JJ category_NN ._. We_PRP selected_VBD it_PRP for_IN this_DT
        study_NN because_IN it_PRP is_VBZ rapidly_RB bactericidal_NN ,_, functions_NNS well_RB at_IN
        elevated_VBD physiological_JJ salt_NN concentrations_NNS such_JJ as_IN those_DT
        that_WDT may_MD occur_VB in_IN the_DT CF_NNP lung_NN ,_, and_CC has_VBZ a_DT broad_JJ spectrum_NN of_IN
        activity_NN [_NN 21_CD 22_CD 23_CD ]_NN ._. PG-_NNP 1_CD 's_POS antiparallel_NN β-hairpin_JJ
        structure_NN and_CC antimicrobial_NN activity_NN in_IN physiological_JJ and_CC
        elevated_VBD salt_NN concentrations_NNS are_VBP maintained_VBN by_IN its_PRP$ two_CD
        intramolecular_NN cystine_NN disulfide_NN bonds_NNS [_NN 21_CD 24_CD 25_CD 26_CD 27_CD 28_CD
        ]_NN ._. The_DT antimicrobial_NN spectrum_NN of_IN PG-_NNP 1_CD includes_VBZ 
        Chlamydia_NNP trachomatis_NNS ,_, 
        Candida_NNP albicans_NNS ,_, 
        Escherichia_NNP coli_NNS ,_, 
        Fusobacterium_NNP nucleatum_NN ,_, Haemophilus_NNP
        ducreyi_NN ,_, 
        Listeria_NNP monocytogenes_NNS ,_, 
        Neisseria_NNP gonorrhoeae_NN ,_, 
        Porphyromonas_NNP gingivalis_NNS ,_, 
        Prevotella_NNP intermedia_NN ,_, 
        P_NN ._. aeruginosa_NN ,_, and_CC 
        Staphylococcus_NNP aureus_NN [_NN 20_CD 22_CD 25_CD 29_CD
        30_CD 31_CD 32_CD ]_NN ._.
        This_DT study_NN tested_VBD the_DT hypothesis_NNS that_IN the_DT relative_JJ
        sensitivity_NN or_CC resistance_NN of_IN 
        P_NN ._. aeruginosa_NN and_CC 
        B_NNP ._. cepacia_NN strains_NNS to_TO PG-_NNP 1_CD correlates_NNS
        to_TO the_DT extent_NN of_IN peptide_NN binding_JJ ._. A_DT previously_RB described_VBN
        two-stage_JJ radial_NN diffusion_NN technique_NN designed_VBN for_IN peptide_NN
        antibiotics_NNS was_VBD used_VBN to_TO determine_VB susceptibility_NN ._. Binding_NNP
        of_IN protegrins_NNS to_TO intact_JJ 
        P_NN ._. aeruginosa_NN and_CC 
        B_NNP ._. cepacia_NN cells_NNS and_CC to_TO purified_JJ
        lipopolysaccharide_NN (_( LPS_NNP )_) and_CC lipid_NN A_DT prepared_VBN from_IN these_DT
        organisms_NNS was_VBD measured_VBN by_IN three_CD different_JJ techniques_NNS ._.
      
      
        Materials_NNS and_CC methods_NNS
        
          Bacterial_NNP strains_NNS and_CC growth_NN media_NNS
          Two_CD sets_NNS of_IN genetically_RB related_VBN 
          P_NN ._. aeruginosa_NN strains_NNS were_VBD studied_VBN ._.
          Strain_NNP 144_CD M_NNP ,_, a_DT serum-sensitive_JJ mucoid_NN isolate_VB from_IN a_DT CF_NNP
          patient_NN ,_, contains_VBZ short_JJ O-_NNP side_NN chain_NN LPS_NNP ,_, while_IN its_PRP$
          serum-resistant_JJ derivative_NN ,_, 144_CD M_NNP (_( SR_NNP )_) ,_, which_WDT is_VBZ also_RB
          mucoid_NN ,_, has_VBZ long_JJ O-_NNP side_NN chain_NN LPS_NNP [_NN 33_CD ]_NN ._. Strain_NNP FRD-_NNP 1_CD
          is_VBZ a_DT mucoid_NN CF_NNP isolate_VB [_NN 34_CD ]_NN and_CC FRD-_NNP 2_CD is_VBZ its_PRP$
          spontaneous_JJ nonmucoid_NN derivative_JJ [_NN 35_CD ]_NN ._. 
          P_NN ._. aeruginosa_NN ATCC_NNP strains_NNS 10145_CD
          and_CC 9027_CD are_VBP nonmucoid_NN strains_NNS with_IN long_JJ O-_NNP side_NN chain_NN
          LPSs_NNP [_NN N_NNP L_NNP Schiller_NNP ,_, unpublished_JJ results_NNS ]_NN ._. We_PRP also_RB studied_VBD
          
          B_NNP ._. cepacia_NN ATCC_NNP strains_NNS 25416_CD and_CC
          25609_CD ,_, as_RB well_RB as_IN three_CD clinical_JJ strains_NNS isolated_VBN from_IN
          patients_NNS with_IN CF_NNP in_IN Vancouver_NNP ,_, Canada_NNP ,_, kindly_RB provided_VBN by_IN
          David_NNP P_NN Speert_NNP ,_, University_NNP of_IN British_NNP Columbia_NNP ._. These_DT
          strains_NNS included_VBD :_: C_NNP 4813_CD ,_, genomovar_NN IIIa_NNP ,_, 
          B_NNP ._. cepacia_NN epidemic_NN strain_NN marker_NN
          (_( BCESM_NNP )_) positive_JJ ,_, cable_NN pilin_NN subunit_NN gene_NN A_DT (_( cable_NN A_DT )_)
          negative_JJ ;_: C_NNP 4878_CD ,_, genomovar_NN IIIa_NNP ,_, BCESM_NNP positive_NN ,_, cable_NN A_DT
          negative_JJ ;_: and_CC C_NNP 6159_CD ,_, genomovar_NN IIIb_NNP ,_, BCESM_NNP and_CC cable_NN A_DT
          negative_NN ._. BCESM_NNP and_CC cable_NN A_DT are_VBP putative_JJ transmissibility_NN
          markers_NNS [_NN 36_CD ]_NN ._. Log-phase_NNP cultures_NNS were_VBD grown_VBN at_IN 37_CD °_NN C_NNP
          with_IN shaking_VBG in_IN trypticase_NN soy_NN broth_NN (_( TSB_NNP )_)
          (_( Becton-_NNP Dickinson_NNP Microbiology_NNP ,_, Cockeysville_NNP ,_, MD_NNP )_) ._.
        
        
          Protegrin_NNP
          PG-_NNP 1_CD was_VBD prepared_VBN as_RB previously_RB described_VBD [_NN 25_CD ]_NN and_CC
          was_VBD approximately_RB 96_CD ._. 5_LS %_NN pure_JJ ._. PG-_NNP 1_CD was_VBD dissolved_VBN in_IN and_CC
          diluted_VBN with_IN filter-sterilized_JJ acidified_VBN water_NN (_( 0_CD ._. 01_CD %_NN
          acetic_JJ acid_NN )_) supplemented_JJ with_IN 0_CD ._. 1_CD %_NN human_JJ serum_NN albumin_NN
          (_( Sigma_NNP ,_, St_NNP ._. Louis_NNP ,_, MO_NNP )_) ._. The_DT albumin_NN in_IN the_DT PG-_NNP 1_CD vehicle_NN
          helped_VBD reduce_VB nonspecific_JJ adsorption_NN of_IN protegrins_NNS when_WRB
          the_DT stock_NN solutions_NNS were_VBD serially_RB diluted_VBN [_NN 22_CD 37_CD ]_NN ._.
          These_DT PG-_NNP 1_CD stock_NN solutions_NNS were_VBD filter-sterilized_JJ prior_RB
          to_TO storage_NN at_IN either_DT -_: 20_CD °_NN C_NNP for_IN short_JJ term_NN (_( <_NN 3_CD months_NNS )_)
          or_CC -_: 80_CD °_NN C_NNP for_IN long-term_JJ storage_NN ._.
        
        
          Radial_NNP diffusion_NN assay_NN
          The_DT two-stage_JJ radial_NN diffusion_NN assay_NN protocol_NN as_IN
          described_VBN by_IN Steinberg_NNP and_CC Lehrer_NNP [_NN 37_CD ]_NN and_CC Lehrer_NNP 
          et_CC al_NN ._. [_NN 38_CD ]_NN was_VBD altered_VBN by_IN
          supplementing_VBG the_DT underlay_NN agar_NN with_IN 150_CD mM_NN NaCl_NNP to_TO
          ascertain_VB PG-_NNP 1_CD 's_POS ability_NN to_TO kill_VB 
          P_NN ._. aeruginosa_NN and_CC 
          B_NNP ._. cepacia_NN at_IN an_DT elevated_VBD salt_NN
          concentration_NN ._. These_DT assays_NNS were_VBD interpreted_VBN as_IN described_VBN
          below_IN ._. The_DT sample_NN wells_NNS received_VBD 5_CD μl_NN of_IN PG-_NNP 1_CD (_( various_JJ
          concentrations_NNS )_) or_CC its_PRP$ vehicle_NN ._. We_PRP analyzed_VBD the_DT radial_NN
          diffusion_NN assay_NN results_NNS in_IN two_CD ways_NNS ._. In_IN one_CD ,_, we_PRP
          calculated_VBD the_DT lethal_JJ concentration_NN (_( C_NNP 
          L_NNP )_) as_IN described_VBN by_IN Hultmark_NNP 
          et_CC al_NN ._. [_NN 39_CD 40_CD ]_NN from_IN wells_NNS
          surrounded_VBN by_IN net_JJ clear_JJ zones_NNS of_IN 1_CD to_TO 2_CD ._. 5_CD mm_NN ._. In_IN the_DT
          other_JJ ,_, we_PRP defined_VBD the_DT minimal_JJ active_JJ concentration_NN (_( MAC_NNP )_)
          as_IN the_DT lowest_JJS concentration_NN of_IN PG-_NNP 1_CD that_WDT produced_VBD a_DT
          measurable_JJ ,_, totally_RB clear_JJ ,_, inhibition_NN zone_NN around_IN the_DT
          well_NN ._.
        
        
          Whole_JJ cell_NN binding_JJ assay_NN
          Binding_NNP of_IN PG-_NNP 1_CD to_TO intact_JJ cells_NNS was_VBD measured_VBN with_IN a_DT
          monoradioiodinated_JJ variant_NN of_IN PG-_NNP 1_CD ._. This_DT protegrin_NN
          variant_NN differed_VBD from_IN PG-_NNP 1_CD in_IN two_CD ways_NNS :_: Phe_NNP 7_CD replaced_VBN
          Tyr_NNP 7_CD in_IN the_DT protegrin_NN domain_NN ,_, and_CC an_DT N-_NNP terminal_NN
          glycine-rich_JJ hexapeptide_NN extension_NN (_( GGGYGG_NNP )_) with_IN a_DT single_JJ
          tyrosine_NN residue_NN was_VBD present_JJ ._. In_IN this_DT report_NN the_DT modified_VBN
          peptide_NN and_CC its_PRP$ monoiodinated_JJ variant_NN will_MD be_VB called_VBN
          "_'' GGPG_NNP "_'' and_CC "_'' I-GGPG_NNP "_'' ,_, respectively_RB ._. The_DT full_JJ sequence_NN of_IN
          GGPG_NNP is_VBZ GGGYGGRGGRLCFCRRRFCVCVGR-CONH_NNP 
          2_CD ._. In_IN preliminary_JJ experiments_NNS ,_, we_PRP
          determined_VBD that_IN PG-_NNP 1_CD ,_, GGPG_NNP ,_, and_CC I-GGPG_NNP exhibited_VBN
          virtually_RB identical_JJ antimicrobial_NN potency_NN and_CC kinetics_NNS
          (_( data_NNS not_RB shown_VBN )_) ._.
          GGPG_NNP was_VBD iodinated_JJ with_IN NaI_NNP or_CC Na_NNP 125_CD I_PRP (_( Pierce_NNP ,_,
          Rockford_NNP ,_, IL_NNP )_) by_IN the_DT iodobead_NN method_NN [_NN 41_CD 42_CD ]_NN ._.
          Unincorporated_NNP NaI_NNP or_CC Na_NNP 125_CD I_PRP was_VBD removed_VBN by_IN solid_JJ phase_NN
          extraction_NN on_IN a_DT Sep-_NNP Pak_NNP C-_NNP 18_CD Plus_NNP Cartridge_NNP ._. I-GGPG_NNP was_VBD
          purified_JJ from_IN uniodinated_JJ and_CC di-iodinated_JJ GGPG_NNP by_IN
          reverse_NN phase-_NN HPLC_NNP (_( Vydac_NNP ,_, Hesperia_NNP ,_, CA_NNP )_) ._. Binding_NNP assays_NNS
          were_VBD done_VBN with_IN stationary_JJ phase_NN 
          P_NN ._. aeruginosa_NN 9027_CD or_CC 
          B_NNP ._. cepacia_NN 25416_CD ,_, both_DT typically_RB at_IN
          2_CD ._. 5_CD ×_NN 10_CD 7_CD CFU_NNP /_NN ml_NN ._. The_DT bacteria_NNS were_VBD incubated_JJ with_IN
          125_CD I-GGPG_NNP at_IN 0_CD °_NN C_NNP for_IN 60_CD min_NN at_IN pH_NN 7_CD ._. 4_CD in_IN a_DT 10_CD mM_NN
          Tris-acetate_NNP buffer_NN containing_VBG 100_CD mM_NN NaCl_NNP ,_, 1_CD %_NN TSB_NNP ,_, and_CC
          1_CD %_NN BSA_NNP ._. Samples_NNP were_VBD layered_JJ over_IN 0_CD ._. 3_CD ml_NN of_IN a_DT cushion_NN
          composed_VBN of_IN 5_CD parts_NNS of_IN dibutyl_NN phthalate_NN and_CC 3_CD parts_NNS of_IN
          di-isodecyl_JJ phthalate_NN (_( density_NN 
          20_CD =_SYM 1_CD ._. 01_CD )_) and_CC centrifuged_JJ at_IN
          approximately_RB 14_CD ,_, 000_CD ×_NN 
          g_SYM ._. After_IN removing_VBG the_DT supernatant_NN
          and_CC phthalate_NN oil_NN ,_, the_DT base_NN of_IN the_DT tube_NN was_VBD severed_VBN with_IN
          a_DT razor_NN blade_NN and_CC the_DT stub_NN ,_, which_WDT contained_VBD the_DT pellet_NN ,_,
          was_VBD recovered_VBN for_IN radioactivity_NN counting_NN ._.
        
        
          LPS_NNP and_CC lipid_NN A_DT extraction_NN and_CC analysis_NN
          Bacterial_NNP LPS_NNP was_VBD isolated_VBN according_VBG to_TO the_DT protocol_NN
          of_IN Darveau_NNP and_CC Hancock_NNP [_NN 43_CD ]_NN with_IN some_DT modifications_NNS ,_, as_IN
          described_VBN below_IN ._. Strains_NNP were_VBD grown_VBN overnight_JJ in_IN TSB_NNP ,_,
          collected_VBN via_IN centrifugation_NN (_( 10_CD ,_, 000_CD ×_NN 
          g_SYM for_IN 20_CD min_NN at_IN 0_CD °_NN C_NNP )_) ,_, and_CC suspended_VBD
          in_IN a_DT pH_NN 8_CD ._. 0_CD buffer_NN (_( 5_CD ._. 0_CD g_SYM of_IN wet_JJ weight_NN bacteria_NNS /_NN 30_CD ml_NN of_IN
          buffer_NN )_) that_WDT contained_VBD 10_CD mM_NN Tris-hydrochloride_NNP ,_, 2_CD mM_NN
          MgCl_NNP 
          2_CD ,_, 100_CD μg_NN /_NN ml_NN DNase_NNP I_PRP ,_, and_CC 25_CD μg_NN /_NN ml_NN
          RNase_NNP I_PRP ._. The_DT slurry_NN was_VBD passed_VBN twice_RB through_IN a_DT French_NNP
          Press_NNP set_VBD at_IN 20_CD ,_, 000_CD lbs_NNS /_NN in_IN 2_CD ._. DNase_NNP and_CC RNase_NNP were_VBD again_RB
          added_VBN ,_, and_CC the_DT mixture_NN was_VBD incubated_JJ at_IN 37_CD °_NN C_NNP for_IN 2_CD hours_NNS ._.
          Then_RB ,_, to_TO each_DT 15_CD ml_NN of_IN suspension_NN ,_, the_DT following_VBG were_VBD
          added_VBN :_: 5_CD ._. 0_CD ml_NN of_IN 0_CD ._. 5_CD M_NNP tetrasodium_NN EDTA_NNP in_IN 10_CD mM_NN Tris_NNP
          buffer_NN ,_, 2_CD ._. 5_CD ml_NN of_IN 20_CD %_NN SDS_NNP in_IN 10_CD mM_NN Tris_NNP buffer_NN ,_, and_CC 2_CD ._. 5_CD
          ml_NN of_IN 10_CD mM_NN Tris_NNP buffer_NN ._. The_DT preparation_NN was_VBD mixed_JJ and_CC
          centrifuged_JJ at_IN 50_CD ,_, 000_CD ×_NN 
          g_SYM for_IN 30_CD min_NN at_IN 20_CD °_NN C_NNP to_TO remove_VB the_DT
          peptidoglycan_NN ._. Protease_NNP (_( Sigma_NNP P_NN 5147_CD )_) at_IN 200_CD μg_NN /_NN ml_NN was_VBD
          added_VBN to_TO the_DT supernatant_NN and_CC incubated_JJ at_IN 37_CD °_NN C_NNP overnight_JJ
          with_IN agitation_NN ._. On_IN the_DT next_JJ day_NN ,_, 0_CD ._. 375_CD M_NNP MgCl_NNP 
          2_CD in_IN 95_CD %_NN ethanol_NN was_VBD added_VBN and_CC the_DT
          suspension_NN was_VBD cooled_VBN to_TO 0_CD °_NN C_NNP before_IN centrifugation_NN at_IN
          12_CD ,_, 000_CD ×_NN 
          g_SYM for_IN 15_CD min_NN at_IN 0_CD °_NN C_NNP ._. The_DT resulting_VBG
          pellet_NN was_VBD resuspended_JJ in_IN 2_CD %_NN SDS_NNP ,_, 0_CD ._. 1_CD M_NNP tetrasodium_NN EDTA_NNP
          in_IN 10_CD mM_NN Tris_NNP buffer_NN and_CC sonicated_JJ ._. This_DT solution_NN was_VBD
          incubated_JJ at_IN 85_CD °_NN C_NNP for_IN 30_CD min_NN ,_, and_CC cooled_VBD to_TO room_NN
          temperature_NN before_IN protease_NN (_( 25_CD μg_NN /_NN ml_NN )_) was_VBD added_VBN and_CC
          incubated_JJ overnight_JJ at_IN 37_CD °_NN C_NNP ._. After_IN re-precipitation_JJ the_DT
          following_VBG day_NN with_IN ethanol_NN ,_, the_DT pellet_NN was_VBD resuspended_JJ in_IN
          10_CD mM_NN Tris_NNP buffer_NN and_CC centrifuged_JJ at_IN 200_CD ,_, 000_CD ×_NN 
          g_SYM for_IN 2_CD hours_NNS at_IN 20_CD °_NN C_NNP in_IN the_DT
          presence_NN of_IN 25_CD mM_NN MgCl_NNP 
          2_CD ._. The_DT final_JJ LPS_NNP extract_VB was_VBD
          suspended_VBN in_IN 10_CD ml_NN dH_NN 
          2_CD O_NNP and_CC dialyzed_JJ overnight_JJ against_IN dH_NN 
          2_CD O_NNP to_TO remove_VB any_DT residual_JJ salt_NN and_CC
          SDS_NNP prior_RB to_TO being_VBG lyophilized_JJ ._. Contamination_NNP of_IN the_DT LPS_NNP
          samples_NNS by_IN protein_NN represented_VBD no_RB more_JJR than_IN 3_CD ._. 6_CD %_NN ±_NN 0_CD ._. 21_CD %_NN ,_,
          as_IN estimated_VBN by_IN measuring_VBG the_DT dry_JJ weight_NN and_CC protein_NN
          concentration_NN with_IN the_DT Bio-_NNP Rad_NNP Protein_NNP Assay_NNP Kit_NNP ._. Nucleic_NNP
          acid_NN contamination_NN was_VBD considered_VBN to_TO be_VB minimal_JJ due_NN to_TO
          the_DT repeated_VBN DNase_NNP and_CC RNase_NNP treatments_NNS ._. LPS_NNP preparations_NNS
          were_VBD diluted_VBN using_VBG the_DT PG-_NNP 1_CD vehicle_NN prior_RB to_TO assaying_VBG
          with_IN PG-_NNP 1_CD ._.
          Lipid_NNP A_DT was_VBD extracted_VBN from_IN isolated_VBN LPS_NNP preparations_NNS
          via_IN acid_NN hydrolysis_NNS [_NN 44_CD 45_CD ]_NN ._. Isolated_NNP LPS_NNP (_( 25_CD -_: 30_CD mg_NN )_)
          was_VBD suspended_VBN in_IN 4_CD ml_NN of_IN a_DT 1_CD %_NN acetic_JJ acid_NN solution_NN and_CC
          heated_JJ in_IN a_DT water_NN bath_NN to_TO 100_CD °_NN C_NNP under_IN refluxing_VBG
          conditions_NNS for_IN 3_CD hours_NNS ._. Once_RB the_DT lipid_NN A_DT was_VBD hydrolyzed_JJ ,_,
          it_PRP precipitated_VBD out_IN of_IN solution_NN and_CC was_VBD extracted_VBN with_IN
          five_CD sequential_NN 4_CD ml_NN aliquots_NNS of_IN chloroform_NN ._. Lipid_NNP A_DT
          extracts_NNS were_VBD collected_VBN and_CC washed_VBN three_CD times_NNS with_IN 10_CD ml_NN
          aliquots_NNS of_IN dH_NN 
          2_CD O_NNP before_IN being_VBG lyophilized_JJ ._. Lipid_NNP A_DT
          was_VBD dissolved_VBN in_IN 100_CD %_NN dimethyl_NN sulfoxide_NN (_( DMSO_NNP )_) ,_, which_WDT
          was_VBD diluted_VBN to_TO 2_CD ._. 5_CD %_NN with_IN the_DT PG-_NNP 1_CD vehicle_NN before_IN
          application_NN in_IN the_DT radial_NN diffusion_NN assay_NN ._.
          In_IN order_NN to_TO measure_VB the_DT ability_NN of_IN LPS_NNP and_CC lipid_NN A_DT to_TO
          bind_NN PG-_NNP 1_CD ,_, we_PRP modified_VBN the_DT two_CD stage_NN radial_NN diffusion_NN
          assay_NN so_IN that_IN we_PRP could_MD ascertain_VB the_DT amount_NN of_IN LPS_NNP or_CC
          lipid_NN A_DT (_( in_IN ng_NN )_) ,_, that_WDT reduced_VBD the_DT antimicrobial_NN activity_NN
          of_IN 50_CD ng_NN of_IN PG-_NNP 1_CD by_IN 50_CD percent_NN (_( called_VBD the_DT effective_JJ
          concentration_NN 50_CD %_NN or_CC EC_NNP 
          50_CD )_) ._. Briefly_NNP ,_, 2_CD ._. 5_CD μl_NN of_IN a_DT 20_CD μg_NN /_NN ml_NN
          PG-_NNP 1_CD solution_NN and_CC 2_CD ._. 5_CD μl_NN of_IN LPS_NNP or_CC lipid_NN A_DT (_( at_IN various_JJ
          concentrations_NNS based_VBN on_IN their_PRP$ dry_JJ weight_NN )_) were_VBD combined_VBN ,_,
          and_CC added_VBD to_TO the_DT radial_NN diffusion_NN wells_NNS ._. After_IN a_DT 3_CD -_: hour_NN
          incubation_NN ,_, a_DT nutrient_NN rich_JJ overlay_NN gel_NN was_VBD poured_VBN and_CC
          the_DT plates_NNS were_VBD incubated_JJ overnight_JJ ._. The_DT following_VBG day_NN ,_,
          zone_NN diameters_NNS (_( including_VBG the_DT wells_NNS )_) were_VBD measured_VBN in_IN mm_NN ._.
          Since_IN the_DT height_NN (_( h_NN )_) of_IN the_DT underlay_NN gel_NN was_VBD always_RB 1_CD ._. 2_CD
          mm_NN ,_, the_DT zone_NN diameters_NNS were_VBD converted_VBN to_TO volumes_NNS cleared_VBD
          of_IN viable_JJ bacteria_NNS with_IN the_DT formula_NN for_IN the_DT volume_NN of_IN a_DT
          cylinder_NN :_: V_NNP =_SYM π_NN r_LS 2_CD h_NN ._. Since_IN the_DT 3_CD mm_NN diameter_NN sample_NN well_RB
          was_VBD devoid_JJ of_IN both_DT bacteria_NNS and_CC peptide_NN ,_, its_PRP$ volume_NN (_( 8_CD ._. 5_LS
          μl_NN )_) was_VBD subtracted_VBN from_IN the_DT gross_JJ clear_JJ zone_NN volume_NN (_( π_NN r_LS
          2_CD h_NN )_) to_TO derive_VB the_DT net_JJ volume_NN rendered_VBD free_JJ of_IN bacteria_NNS ._.
          As_IN will_MD be_VB shown_VBN below_IN ,_, this_DT net_JJ volume_NN was_VBD a_DT linear_JJ
          function_NN of_IN the_DT amount_NN of_IN PG-_NNP 1_CD placed_VBN in_IN the_DT well_NN ,_, for_IN
          amounts_NNS of_IN protegrin_NN between_IN 0_CD -_: 50_CD ng_NN /_NN well_RB ._.
        
        
          Surface_NNP plasmon_NN resonance_NN
          Binding_NNP of_IN LPS_NNP or_CC lipid_NN A_DT to_TO PG-_NNP 1_CD was_VBD assessed_VBN with_IN a_DT
          Biacore_NNP 2000_CD system_NN (_( BiaCore_NNP AB_NNP ,_, Piscataway_NNP ,_, NJ_NNP )_) ;_: a_DT very_RB
          similar_JJ approach_NN was_VBD used_VBN to_TO study_VB LPS_NNP binding_JJ by_IN peptide_NN
          domains_NNS of_IN horseshoe_NN crab_NN factor_NN C_NNP [_NN 46_CD ]_NN ._. This_DT
          innovative_JJ technology_NN uses_VBZ surface_NN plasmon_NN resonance_NN to_TO
          study_VB biomolecular_NN interactions_NNS in_IN real_JJ time_NN ._. Briefly_NNP ,_,
          the_DT binding_JJ takes_VBZ place_NN on_IN a_DT small_JJ chip_NN coated_VBN with_IN a_DT
          thin_JJ layer_NN of_IN metal_NN ._. It_PRP is_VBZ monitored_VBN by_IN monochromatic_JJ ,_,
          p-polarized_JJ light_JJ whose_WP$ electric_JJ vector_NN component_NN is_VBZ
          parallel_JJ to_TO the_DT plane_NN of_IN incidence_NN ._. Under_IN these_DT
          conditions_NNS ,_, the_DT intensity_NN of_IN the_DT reflected_VBN light_NN is_VBZ
          markedly_RB reduced_VBN at_IN a_DT specific_JJ incident_NN angle_NN ,_, producing_VBG
          a_DT sharp_JJ "_'' shadow_NN "_'' ._. This_DT phenomenon_NN is_VBZ called_VBN "_'' surface_NN
          plasmon_NN resonance_NN "_'' (_( SPR_NNP )_) and_CC the_DT incident_NN light_JJ angle_NN at_IN
          which_WDT the_DT shadow_NN is_VBZ observed_VBN is_VBZ the_DT "_'' SPR_NNP angle_NN "_'' ._.
          Detection_NNP of_IN the_DT SPR_NNP angle_NN depends_VBZ on_IN changes_NNS in_IN the_DT
          refractive_JJ index_NN (_( RI_NNP )_) of_IN the_DT medium_NN on_IN the_DT nonilluminated_JJ
          side_NN of_IN the_DT chip_NN ._. Since_IN this_DT RI_NNP depends_VBZ on_IN the_DT mass_NN
          concentration_NN of_IN macromolecules_NNS at_IN this_DT surface_NN ,_,
          monitoring_VBG the_DT SPR_NNP angle_NN provides_VBZ a_DT real-time_JJ measure_NN of_IN
          changes_NNS in_IN the_DT surface_NN concentration_NN ._. The_DT SPR_NNP spectrum_NN is_VBZ
          a_DT plot_NN of_IN the_DT SPR_NNP angle_NN against_IN time_NN ,_, and_CC displays_VBZ the_DT
          interaction_NN 's_POS progress_NN at_IN the_DT sensor_NN surface_NN ._. The_DT SPR_NNP
          signal_NN is_VBZ expressed_VBN in_IN resonance_NN units_NNS (_( RU_NNP )_) ,_, and_CC 1000_CD RU_NNP
          is_VBZ equivalent_JJ to_TO a_DT change_NN in_IN surface_NN protein_NN
          concentration_NN of_IN about_IN 1_CD ng_NN /_NN mm_NN 2_CD or_CC of_IN about_IN 6_CD mg_NN /_NN ml_NN in_IN
          the_DT bulk_NN protein_NN concentration_NN ._.
          In_IN our_PRP$ study_NN ,_, LPS_NNP and_CC lipid_NN A_DT samples_NNS from_IN 
          P_NN ._. aeruginosa_NN 9027_CD and_CC 
          B_NNP ._. cepacia_NN 25416_CD were_VBD immobilized_JJ
          on_IN a_DT hydrophobic_JJ HPA_NNP sensor_NN chip_NN (_( BR-_NNP 1000_CD -_: 30_CD ,_, Biacore_NNP AB_NNP )_)
          that_WDT was_VBD found_VBN ,_, in_IN our_PRP$ preliminary_JJ experiments_NNS ,_, to_TO
          provide_VB an_DT optimal_NN matrix_NN for_IN LPS_NNP and_CC lipid_NN A_DT ._. The_DT
          surface_NN of_IN HPA_NNP sensor_NN chips_NNS is_VBZ composed_VBN of_IN long-chain_JJ
          alkanethiol_NN molecules_NNS that_WDT form_NN a_DT flat_JJ ,_, quasi-crystalline_JJ
          hydrophobic_JJ layer_NN that_WDT facilitates_NNS hydrophobic_JJ adsorption_NN
          of_IN liposomes_NNS or_CC micelles_NNS on_IN a_DT user-defined_JJ polar_JJ lipid_NN
          monolayer_NN ._. The_DT chip_NN was_VBD precleaned_JJ and_CC conditioned_VBN by_IN
          washing_VBG twice_RB with_IN 40_CD mM_NN n-octyl_JJ glucoside_NN (_( Sigma_NNP
          Chemical_NNP Co_NNP ._. )_) ._. To_TO immobilize_NN the_DT LPS_NNP ,_, 60_CD μl_NN of_IN a_DT 1_CD mg_NN /_NN ml_NN
          LPS_NNP preparation_NN was_VBD dispersed_VBD in_IN 100_CD mM_NN NaCl_NNP containing_VBG
          10_CD mM_NN HEPES_NNP buffer_NN (_( pH_NN 7_CD ._. 4_LS )_) ,_, and_CC passed_VBD across_IN the_DT chip_NN 's_POS
          surface_NN for_IN 30_CD min_NN ,_, at_IN flow_NN rate_NN of_IN 2_CD μl_NN /_NN min_NN ._. Lipid_NNP A_DT was_VBD
          dissolved_VBN and_CC immobilized_JJ similarly_RB ,_, except_IN that_DT its_PRP$
          concentration_NN was_VBD reduced_VBN to_TO 0_CD ._. 2_CD mg_NN /_NN ml_NN ._. Residual_NNP unbound_NN
          LPS_NNP and_CC lipid_NN A_DT were_VBD washed_VBN away_RB with_IN 0_CD ._. 1_CD M_NNP HCl_NNP and_CC 0_CD ._. 1_CD M_NNP
          NaOH_NNP ._. BSA_NNP (_( 0_CD ._. 1_LS mg_NN /_NN ml_NN )_) was_VBD used_VBN to_TO detect_VB nonspecific_JJ
          binding_VBG on_IN the_DT surfaces_VBZ coated_VBN by_IN LPS_NNP or_CC lipid_NN A_DT ._. PG-_NNP 1_CD
          binding_JJ was_VBD measured_VBN by_IN observing_VBG the_DT change_NN in_IN the_DT SPR_NNP
          angle_NN of_IN the_DT sample_NN bound_VBN to_TO the_DT chip_NN as_IN 30_CD μl_NN of_IN PG-_NNP 1_CD
          (_( 20_CD μM_NN ,_, 10_CD μM_NN ,_, 6_CD μM_NN ,_, 3_CD μM_NN ,_, 2_CD μM_NN ,_, and_CC 1_CD μM_NN )_) flowed_VBD over_IN
          the_DT sample_NN for_IN 3_CD min_NN at_IN a_DT rate_NN of_IN 10_CD μl_NN /_NN min_NN ._. These_DT PG-_NNP 1_CD
          solutions_NNS were_VBD also_RB prepared_VBN in_IN 100_CD mM_NN NaCl_NNP containing_VBG 10_CD
          mM_NN HEPES_NNP buffer_NN (_( pH_NN 7_CD ._. 4_LS )_) ._. Each_DT binding_JJ study_NN was_VBD done_VBN in_IN
          triplicate_NN and_CC the_DT chip_NN was_VBD regenerated_JJ between_IN trials_NNS by_IN
          washing_VBG it_PRP with_IN 0_CD ._. 1_CD M_NNP HCl_NNP and_CC 0_CD ._. 1_CD M_NNP NaOH_NNP ._.
        
      
      
        Results_NNS
        
          Activity_NN of_IN PG-_NNP 1_CD on_IN P_NN ._. aeruginosaand_NN B_NNP ._.
          cepaciastrains_NNS
          The_DT C_NNP 
          L_NNP and_CC MAC_NNP for_IN PG-_NNP 1_CD on_IN 
          P_NN ._. aeruginosa_NN and_CC 
          B_NNP ._. cepacia_NN were_VBD determined_VBN in_IN
          two-stage_JJ radial_NN diffusion_NN assays_NNS (_( Table_NNP 1_LS )_) ._. The_DT mean_NN C_NNP 
          L_NNP of_IN PG-_NNP 1_CD for_IN the_DT six_CD 
          P_NN ._. aeruginosa_NN strains_NNS was_VBD 0_CD ._. 30_CD
          μg_NN /_NN ml_NN ,_, and_CC the_DT mean_NN C_NNP 
          L_NNP for_IN the_DT five_CD 
          B_NNP ._. cepacia_NN strains_NNS was_VBD 5_CD ._. 02_CD μg_NN /_NN ml_NN ,_,
          a_DT 16_CD ._. 7_CD -_: fold_VB difference_NN ._. The_DT mean_NN MACs_NNP for_IN 
          P_NN ._. aeruginosa_NN and_CC 
          B_NNP ._. cepacia_NN were_VBD 0_CD ._. 17_CD μg_NN /_NN ml_NN and_CC 8_CD ._. 40_CD
          μg_NN /_NN ml_NN ,_, respectively_RB ._. The_DT C_NNP 
          L_NNP and_CC MAC_NNP values_NNS for_IN 
          P_NN ._. aeruginosa_NN and_CC 
          B_NNP ._. cepacia_NN differed_VBD significantly_RB (_(
          
          P_NN exact_JJ =_SYM 0_CD ._. 004_CD )_) when_WRB the_DT data_NNS were_VBD
          analyzed_VBN by_IN the_DT Mann-_NNP Whitney_NNP test_NN ._.
          We_PRP also_RB compared_VBD two_CD sets_NNS of_IN genetically_RB related_VBN 
          P_NN ._. aeruginosa_NN strains_NNS :_:
          144_CD M_NNP /_NN 144_CD M_NNP (_( SR_NNP )_) and_CC FRD-_NNP 1_CD /_NN FRD-_NNP 2_CD ._. Whereas_IN the_DT LPS_NNP of_IN strain_NN
          144_CD M_NNP has_VBZ a_DT very_RB short_JJ O-_NNP antigen_NN side_NN chain_NN ,_, LPS_NNP from_IN
          strain_NN 144_CD M_NNP (_( SR_NNP )_) has_VBZ a_DT very_RB long_JJ O-_NNP antigen_NN side_NN chain_NN ._.
          However_RB ,_, despite_IN these_DT differences_NNS both_DT strains_NNS had_VBD
          comparable_JJ C_NNP 
          L_NNP and_CC MAC_NNP values_NNS ._. Similarly_RB ,_,
          comparison_NN of_IN the_DT alginate_NN producer_NN FRD-_NNP 1_CD with_IN FRD-_NNP 2_CD ,_, its_PRP$
          spontaneous_JJ nonmucoid_NN derivative_NN ,_, revealed_VBD that_IN both_DT
          strains_NNS had_VBD very_RB similar_JJ C_NNP 
          L_NNP and_CC MAC_NNP values_NNS ._.
        
        
          Intact_NNP /_NN whole_JJ cell_NN binding_JJ
          Incubation_NNP of_IN 125_CD I-GGPG_NNP with_IN intact_JJ 
          P_NN ._. aeruginosa_NN 9027_CD (_( PG-_NNP 1_CD sensitive_JJ )_)
          and_CC 
          B_NNP ._. cepacia_NN 25416_CD (_( PG-_NNP 1_CD resistant_JJ )_)
          cells_NNS demonstrated_VBD a_DT marked_VBN difference_NN in_IN protegrin_NN
          binding_VBG between_IN the_DT two_CD strains_NNS (_( Fig_NNP ._. 1_LS )_) ._. When_WRB the_DT
          bacteria_NNS were_VBD exposed_VBN to_TO 12_CD ._. 5_LS μg_NN 125_CD I-GGPG_NNP /_NN ml_NN ,_,
          approximately_RB sixfold_RB more_JJR protegrin_NN molecules_NNS bound_VBN to_TO 
          P_NN ._. aeruginosa_NN than_IN to_TO 
          B_NNP ._. cepacia_NN ,_, and_CC at_IN an_DT 125_CD I-GGPG_NNP
          concentration_NN of_IN 25_CD μg_NN /_NN ml_NN ,_, 12_CD times_NNS as_IN many_JJ protegrin_NN
          molecules_NNS bound_VBN to_TO 
          P_NN ._. aeruginosa_NN ._. Another_DT factor_NN also_RB
          merits_NNS mention_VBP in_IN this_DT regard_NN ._. By_IN light_JJ microscopy_NN ,_, the_DT 
          B_NNP ._. cepacia_NN cells_NNS appeared_VBD larger_JJR
          than_IN the_DT 
          P_NN ._. aeruginosa_NN cells_NNS ._. By_IN electron_NN
          microscopy_NN ,_, we_PRP found_VBD that_IN the_DT mean_JJ cross_NN sectional_JJ
          diameters_NNS and_CC lengths_NNS of_IN 
          B_NNP ._. cepacia_NN 25416_CD cells_NNS were_VBD 0_CD ._. 755_CD
          μm_NN ×_NN 2_CD ._. 55_CD μm_NN ._. The_DT corresponding_JJ values_NNS for_IN 
          P_NN ._. aeruginosa_NN 9027_CD cells_NNS were_VBD 0_CD ._. 615_CD
          μm_NN ×_NN 2_CD ._. 35_CD μm_NN ._. Assuming_VBG a_DT cylindrical_JJ structure_NN for_IN both_DT ,_,
          we_PRP calculated_VBD that_IN the_DT surface_NN area_NN of_IN the_DT 
          B_NNP ._. cepacia_NN cells_NNS (_( 6_CD ._. 00_CD μm_NN 2_LS )_) was_VBD
          approximately_RB 33_CD %_NN larger_JJR on_IN average_JJ than_IN that_DT of_IN 
          P_NN ._. aeruginosa_NN (_( 4_CD ._. 54_CD μm_NN 2_LS )_) ._.
        
        
          Binding_NNP of_IN PG-_NNP 1_CD to_TO LPS_NNP and_CC lipid_NN A_DT
          To_TO compare_VB binding_JJ of_IN PG-_NNP 1_CD to_TO LPS_NNP and_CC lipid_NN A_DT from_IN 
          P_NN ._. aeruginosa_NN 9027_CD and_CC 
          B_NNP ._. cepacia_NN 25416_CD ,_, we_PRP devised_VBD a_DT
          simple_JJ bioassay_NN based_VBN on_IN the_DT radial_NN diffusion_NN assay_NN ._. As_IN
          shown_VBN in_IN Fig_NNP ._. 2_LS ,_, for_IN protegrin_NN amounts_NNS between_IN 0_CD and_CC 50_CD
          ng_NN ,_, the_DT volume_NN of_IN underlay_NN gel_NN that_WDT was_VBD rendered_VBN
          completely_RB free_JJ of_IN viable_JJ bacteria_NNS was_VBD linearly_RB related_VBN
          to_TO the_DT amount_NN of_IN peptide_NN introduced_VBN into_IN the_DT well_NN ._. By_IN
          mixing_VBG a_DT constant_JJ amount_NN of_IN protegrin_NN (_( within_IN this_DT linear_JJ
          range_NN )_) with_IN graded_JJ amounts_NNS of_IN purified_JJ LPS_NNP and_CC lipid_NN A_DT ,_,
          we_PRP could_MD readily_RB determine_VB how_WRB much_JJ of_IN these_DT ligands_NNS were_VBD
          needed_VBN to_TO reduce_VB the_DT activity_NN of_IN 50_CD ng_NN of_IN PG-_NNP 1_CD by_IN 50_CD %_NN
          (_( the_DT EC_NNP 
          50_CD values_NNS )_) ._. The_DT results_NNS of_IN our_PRP$ assays_NNS
          with_IN LPS_NNP and_CC lipid_NN A_DT purified_JJ from_IN the_DT strains_NNS we_PRP used_VBD in_IN
          the_DT above_JJ 125_CD I-GGPG_NNP binding_JJ studies_NNS are_VBP shown_VBN in_IN Fig_NNP ._. 3_LS A_DT ._.
          The_DT EC_NNP 
          50_CD values_NNS for_IN LPS_NNP isolated_VBD from_IN 
          P_NN ._. aeruginosa_NN and_CC 
          B_NNP ._. cepacia_NN differed_VBD by_IN 4_CD ._. 6_CD -_: fold_VB
          (_( 100_CD ng_NN versus_CC 460_CD ng_NN )_) while_IN the_DT EC_NNP 
          50_CD values_NNS for_IN lipid_NN A_DT isolated_VBN from_IN
          the_DT same_JJ strains_NNS differed_VBD by_IN approximately_RB 16_CD ._. 7_CD -_: fold_VB (_( 60_CD
          ng_NN versus_CC 1000_CD ng_NN )_) ._.
          To_TO ascertain_VB if_IN these_DT findings_NNS were_VBD representative_NN ,_, we_PRP
          prepared_VBD LPS_NNP and_CC lipid_NN A_DT from_IN another_DT pair_NN of_IN bacteria_NNS (_( 
          P_NN ._. aeruginosa_NN FRD-_NNP 2_CD and_CC 
          B_NNP ._. cepacia_NN C_NNP 4813_CD )_) and_CC repeated_VBD the_DT
          studies_NNS ._. The_DT EC_NNP 
          50_CD values_NNS for_IN both_DT LPS_NNP and_CC lipid_NN A_DT
          obtained_VBN from_IN 
          P_NN ._. aeruginosa_NN FRD-_NNP 2_CD were_VBD each_DT 120_CD
          ng_NN ._. The_DT values_NNS for_IN 
          B_NNP ._. cepacia_NN LPS_NNP and_CC lipid_NN A_DT were_VBD
          estimated_VBN as_RB approximately_RB 2050_CD ng_NN for_IN both_DT (_( Fig_NNP ._. 3_LS B_NNP )_) ,_, a_DT
          difference_NN of_IN 17_CD ._. 1_LS -_: fold_VB when_WRB compared_VBN to_TO 
          P_NN ._. aeruginosa_NN FRD-_NNP 2_CD LPS_NNP and_CC lipid_NN
          A_DT ._.
        
        
          Surface_NNP plasmon_NN resonance_NN studies_NNS
          We_PRP also_RB used_VBD SPR_NNP spectroscopy_NN to_TO compare_VB the_DT binding_JJ
          of_IN PG-_NNP 1_CD to_TO LPS_NNP and_CC lipid_NN A_DT purified_JJ from_IN 
          P_NN ._. aeruginosa_NN 9027_CD and_CC 
          B_NNP ._. cepacia_NN 25416_CD ._. Injection_NNP of_IN LPS_NNP
          or_CC lipid_NN A_DT from_IN both_DT strains_NNS was_VBD stopped_VBN when_WRB the_DT
          increase_NN in_IN RU_NNP of_IN both_DT reached_VBN 1000_CD ._. Loosely_NNP bound_VBN
          molecules_NNS were_VBD washed_VBN away_RB by_IN increasing_VBG the_DT flow_NN rate_NN to_TO
          100_CD μl_NN /_NN min_NN ,_, followed_VBN by_IN two_CD ,_, one-minute_JJ short_JJ pulse_NN
          injections_NNS of_IN 100_CD mM_NN NaOH_NNP ._. Injections_NNP of_IN 0_CD ._. 1_CD mg_NN /_NN ml_NN BSA_NNP
          prepared_VBD in_IN the_DT eluent_NN buffer_NN were_VBD passed_VBN across_IN the_DT LPS_NNP
          or_CC lipid_NN A_DT coated_JJ surfaces_VBZ for_IN a_DT five-minute_JJ period_NN and_CC
          showed_VBD an_DT increase_NN of_IN around_IN 100_CD RU_NNP ,_, whereas_IN the_DT same_JJ
          amount_NN of_IN BSA_NNP passed_VBD across_IN the_DT uncoated_JJ ,_, n-octyl_JJ
          glucoside_NN washed_VBD surface_NN showed_VBD an_DT increase_NN of_IN roughly_RB
          1000_CD RU_NNP ._. This_DT demonstrated_VBN that_IN the_DT surface_NN of_IN the_DT chip_NN
          was_VBD fully_RB covered_VBN by_IN LPS_NNP or_CC lipid_NN A_DT ._. Since_IN similar_JJ
          amounts_NNS of_IN these_DT ligands_NNS had_VBD bound_VBN to_TO the_DT chip_NN ,_, the_DT
          response_NN unit_NN differences_NNS seen_VBN at_IN concentrations_NNS between_IN
          1_CD and_CC 20_CD μM_NN indicate_VBP that_IN approximately_RB twice_RB as_IN much_JJ
          PG-_NNP 1_CD bound_VBN 
          P_NN ._. aeruginosa_NN lipid_NN A_DT as_IN bound_VBN
          lipid_NN A_DT from_IN the_DT 
          B_NNP ._. cepacia_NN strain_NN (_( Fig_NNP ._. 4_LS )_) ._. Binding_NNP
          differences_NNS were_VBD less_JJR marked_VBD when_WRB we_PRP studied_VBD LPS_NNP from_IN
          these_DT organisms_NNS (_( Fig_NNP ._. 5_LS )_) ._. Although_IN up_IN to_TO one_CD third_JJ more_JJR
          protegrin_NN molecules_NNS bound_VBN to_TO 
          P_NN ._. aeruginosa_NN LPS_NNP than_IN to_TO 
          B_NNP ._. cepacia_NN LPS_NNP at_IN protegrin_NN
          concentrations_NNS of_IN 1_CD -_: 6_CD μM_NN ,_, these_DT differences_NNS disappeared_VBD
          when_WRB we_PRP tested_VBD higher_JJR PG-_NNP 1_CD concentrations_NNS ._. At_IN 10_CD μM_NN PG-_NNP 1_CD ,_,
          LPS_NNP from_IN 
          P_NN ._. aeruginosa_NN and_CC 
          B_NNP ._. cepacia_NN bound_VBN PG-_NNP 1_CD equally_RB (_( ≈_NN
          750_CD response_NN units_NNS )_) ._. Equal_NNP binding_JJ was_VBD also_RB seen_VBN at_IN 20_CD μM_NN
          PG-_NNP 1_CD (_( ≈_NN 1000_CD response_NN units_NNS )_) ._.
        
      
      
        Discussion_NNP
        In_IN this_DT study_NN we_PRP compared_VBD the_DT sensitivity_NN of_IN 
        P_NN ._. aeruginosa_NN and_CC 
        B_NNP ._. cepacia_NN strains_NNS to_TO protegrin_NN PG-_NNP 1_CD
        with_IN the_DT ability_NN of_IN the_DT intact_JJ bacteria_NNS and_CC key_JJ components_NNS
        of_IN their_PRP$ outer_JJ membranes_NNS (_( LPS_NNP and_CC lipid_NN A_DT )_) to_TO bind_NN this_DT
        peptide_NN ._. The_DT indices_NNS of_IN susceptibility_NN (_( C_NNP 
        L_NNP and_CC MAC_NNP values_NNS )_) obtained_VBN from_IN our_PRP$
        radial_NN diffusion_NN assays_NNS established_VBN that_DT 
        P_NN ._. aeruginosa_NN was_VBD considerably_RB more_RBR
        sensitive_JJ to_TO PG-_NNP 1_CD than_IN 
        B_NNP ._. cepacia_NN ._. We_PRP also_RB found_VBD that_IN at_IN
        any_DT given_VBN peptide_NN concentration_NN ,_, many_JJ fewer_JJR protegrin_NN
        molecules_NNS bound_VBN to_TO intact_JJ 
        B_NNP ._. cepacia_NN and_CC its_PRP$ lipid_NN A_DT than_IN to_TO
        the_DT corresponding_JJ 
        P_NN ._. aeruginosa_NN preparations_NNS ._. In_IN model_NN
        systems_NNS ,_, the_DT ability_NN of_IN protegrins_NNS to_TO permeabilize_NN
        membranes_NNS shows_VBZ pronounced_VBN "_'' concentration-gating_JJ "_'' ,_, an_DT
        indication_NN that_IN it_PRP is_VBZ influenced_VBN by_IN the_DT density_NN of_IN bound_VBN
        protegrin_NN molecules_NNS per_IN unit_NN area_NN of_IN membrane_NN [_NN 47_CD ]_NN ._. As_IN
        prior_JJ quantitative_JJ studies_NNS of_IN peptide_NN binding_JJ are_VBP few_JJ in_IN
        number_NN ,_, some_DT readers_NNS may_MD be_VB surprised_VBN to_TO note_VB that_DT Fig_NNP ._.
        1_LS shows_VBZ many_JJ millions_NNS of_IN protegrin_NN molecules_NNS are_VBP bound_VBN to_TO an_DT
        average_JJ bacterial_JJ cell_NN ,_, even_RB at_IN concentrations_NNS around_IN the_DT
        minimal_JJ active_JJ concentration_NN ._. To_TO acquire_VB an_DT equivalent_NN
        density_NN of_IN surface-bound_JJ PG-_NNP 1_CD molecules_NNS ,_, 
        B_NNP ._. cepacia_NN needed_VBD exposure_NN to_TO much_RB
        higher_JJR concentrations_NNS of_IN PG-_NNP 1_CD than_IN 
        P_NN ._. aeruginosa_NN ._. Thus_RB ,_, it_PRP is_VBZ a_DT
        reasonable_JJ inference_NN that_IN the_DT relative_JJ resistance_NN of_IN 
        B_NNP ._. cepacia_NN to_TO PG-_NNP 1_CD is_VBZ a_DT consequence_NN
        of_IN the_DT smaller_JJR number_NN of_IN protegrin_NN molecules_NNS bound_VBN per_IN unit_NN
        area_NN of_IN bacterial_JJ surface_NN ._.
        Earlier_JJR studies_NNS have_VBP shown_VBN that_IN certain_JJ structural_JJ
        differences_NNS in_IN the_DT LPS_NNP of_IN Gram-negative_NNP bacteria_NNS correlate_VBP
        with_IN their_PRP$ susceptibility_NN or_CC resistance_NN to_TO antimicrobial_NN
        (_( lipo_NN )_) peptides_NNS [_NN 19_CD 23_CD 48_CD 49_CD 50_CD 51_CD ]_NN ._. Particular_NNP attention_NN
        has_VBZ been_VBN given_VBN to_TO alterations_NNS of_IN the_DT outer_JJ membrane_NN that_WDT
        could_MD modify_VB binding_VBG to_TO the_DT cell_NN surface_NN ._. For_IN example_NN ,_,
        sensitivity_NN to_TO the_DT antibacterial_NN lipopeptide_NN polymyxin_NN B_NNP is_VBZ
        affected_VBN by_IN the_DT PmrA-PmrB_NNP regulon_NN ,_, which_WDT mediates_NNS
        substitution_NN of_IN 4_CD -_: aminoarabinose_NN on_IN the_DT 4_CD ´_NN phosphate_NN of_IN
        lipid_NN A_DT [_NN 52_CD 53_CD ]_NN ._. By_IN reducing_VBG the_DT negative_JJ charge_NN of_IN
        lipid_NN A_DT ,_, this_DT modification_NN decreases_VBZ its_PRP$ electrostatic_JJ
        interaction_NN with_IN cationic_JJ peptides_NNS ._. Resistance_NNP to_TO polymyxin_NN
        B_NNP is_VBZ also_RB imparted_JJ by_IN the_DT absence_NN or_CC masking_VBG of_IN critical_JJ
        binding_JJ sites_NNS required_VBN for_IN polycation-mediated_JJ
        permeabilization_NN of_IN the_DT outer_JJ membrane_NN [_NN 54_CD ]_NN ._. Thus_RB ,_,
        attachment_NN of_IN polymyxin_NN B_NNP to_TO 
        Yersinia_NNP enterocolitica_NN is_VBZ reduced_VBN by_IN
        steric_JJ hindrance_NN generated_VBN by_IN the_DT size_NN and_CC /_NN or_CC branched_VBN
        shape_NN of_IN the_DT outer_JJ core_NN region_NN of_IN its_PRP$ LPS_NNP macromolecule_NN [_NN
        55_CD ]_NN ._. Additionally_RB ,_, resistance_NN to_TO cationic_JJ peptides_NNS can_MD be_VB
        due_JJ to_TO cytoplasmic_JJ clearance_NN of_IN the_DT antimicrobial_NN peptide_NN
        by_IN an_DT efflux_NN pump_NN ;_: e_SYM ._. g_SYM ._. ,_, 
        Yersinia_NNP resistance_NN to_TO polymyxin_NN B_NNP
        caused_VBN by_IN the_DT RosA_NNP /_NN RosB_NNP efflux_NN pump_NN /_NN potassium_NN antiporter_NN [_NN
        56_CD ]_NN and_CC 
        Neisseria_NNP gonorrhoeae_NN resistance_NN to_TO
        protegrin_NN PG-_NNP 1_CD via_IN an_DT energy-dependent_JJ efflux_NN system_NN termed_VBD
        mtr_NN [_NN 57_CD ]_NN ._.
        Given_VBN the_DT notorious_JJ resistance_NN of_IN 
        B_NNP ._. cepacia_NN to_TO conventional_JJ
        antibiotics_NNS [_NN 2_CD ]_NN ,_, its_PRP$ relative_JJ resistance_NN to_TO PG-_NNP 1_CD was_VBD not_RB
        unexpected_JJ ._. What_WP bacterial_JJ properties_NNS influenced_VBD
        sensitivity_NN to_TO protegrins_NNS ?_. Certainly_RB ,_, the_DT striking_JJ
        correlation_NN with_IN the_DT extent_NN of_IN protegrin_NN binding_JJ must_MD be_VB
        one_CD of_IN these_DT ._. Our_PRP$ studies_NNS with_IN genetically_RB related_VBN 
        P_NN ._. aeruginosa_NN strains_NNS did_VBD not_RB
        implicate_VB the_DT length_NN of_IN the_DT O-_NNP antigen_NN side_NN chain_NN as_IN a_DT key_JJ
        factor_NN ._. Furthermore_RB ,_, genetically_RB related_VBN 
        P_NN ._. aeruginosa_NN strains_NNS that_WDT differed_VBD
        in_IN alginate_NN production_NN were_VBD equally_RB sensitive_JJ to_TO PG-_NNP 1_CD ._. Both_DT
        results_NNS were_VBD somewhat_RB surprising_JJ ,_, since_IN long_JJ O-_NNP side_NN chain_NN
        and_CC alginate_NN molecules_NNS should_MD both_DT bind_NN PG-_NNP 1_CD ._. Perhaps_RB
        limited_JJ alginate_NN production_NN under_IN our_PRP$ experimental_JJ
        conditions_NNS explains_VBZ its_PRP$ failure_NN to_TO influence_VB susceptibility_NN
        to_TO PG-_NNP 1_CD ._. Additional_JJ studies_NNS focusing_VBG on_IN the_DT influence_NN of_IN
        alginate_NN on_IN PG-_NNP 1_CD activity_NN in_IN a_DT biofilm_NN model_NN are_VBP in_IN
        progress_NN ._.
        Why_WRB did_VBD fewer_JJR protegrin_NN molecules_NNS bind_NN to_TO 
        B_NNP ._. cepacia_NN than_IN to_TO 
        P_NN ._. aeruginosa_NN ?_. Our_PRP$ radial_NN
        diffusion_NN /_NN binding_JJ and_CC SPR_NNP studies_NNS strongly_RB implicated_VBN lipid_NN
        A_DT as_IN a_DT prime_JJ suspect_NN in_IN the_DT case_NN ._. The_DT acyl_NN chains_NNS of_IN lipid_NN
        A_DT form_NN an_DT integral_JJ part_NN of_IN the_DT outer_JJ membrane_NN bilayer_NN ,_, and_CC
        electrostatic_JJ or_CC hydrophobic_JJ binding_JJ of_IN protegrin_NN to_TO lipid_NN
        A_DT could_MD easily_RB disturb_VB the_DT organization_NN and_CC acyl-chain_JJ
        packing_NN of_IN the_DT outer_JJ membrane_NN ,_, both_DT vital_JJ in_IN maintaining_VBG
        its_PRP$ integrity_NN and_CC barrier_NN function_NN ._. Accepting_NNP a_DT direct_JJ
        proportionality_NN between_IN measured_VBN plasmon_NN resonance_NN (_( RU_NNP )_) and_CC
        the_DT extent_NN of_IN peptide_NN bound_VBN to_TO the_DT sensor_NN surface_NN ,_, the_DT
        responses_NNS shown_VBN in_IN Fig_NNP ._. 4_LS indicate_VBP that_IN at_IN saturation_NN (_( 20_CD
        μM_NN )_) ,_, lipid_NN A_DT from_IN 
        B_NNP ._. cepacia_NN bound_VBN almost_RB exactly_RB
        one-half_JJ as_IN many_JJ protegrin_NN molecules_NNS as_IN lipid_NN A_DT from_IN 
        P_NN ._. aeruginosa_NN ._. How_WRB might_MD this_DT be_VB
        rationalized_JJ ?_.
        Lipid_NNP A_DT typically_RB contains_VBZ two_CD phosphate_NN groups_NNS ,_, one_CD on_IN
        each_DT glucosamine_NN residue_NN ._. In_IN the_DT lipid_NN A_DT of_IN 
        B_NNP ._. cepacia_NN ,_, one_CD of_IN these_DT phosphates_NNS
        is_VBZ modified_VBN by_IN a_DT phosphodiester-linked_JJ
        4_CD -_: amino-_NN 4_CD -_: deoxyarabinose_NN residue_NN [_NN 58_CD 59_CD ]_NN ._. It_PRP is_VBZ
        noteworthy_JJ that_IN a_DT previous_JJ study_NN reported_VBD that_IN the_DT
        phosphate_NN content_NN of_IN 
        B_NNP ._. cepacia_NN LPS_NNP was_VBD only_RB one-third_NN of_IN
        that_DT of_IN 
        P_NN ._. aeruginosa_NN [_NN 60_CD ]_NN ._. If_IN most_JJS of_IN the_DT
        
        P_NN ._. aeruginosa_NN lipid_NN A_DT phosphates_NNS are_VBP
        unmodified_JJ ,_, and_CC if_IN these_DT phosphates_NNS are_VBP principal_JJ protegrin_NN
        binding_JJ sites_NNS ,_, then_RB one_PRP would_MD expect_VB exactly_RB the_DT results_NNS
        shown_VBN in_IN Fig_NNP ._. 4_LS ._. This_DT is_VBZ also_RB consistent_JJ with_IN the_DT
        suggestion_NN ,_, made_VBN in_IN a_DT recent_JJ report_NN showing_VBG that_IN cystic_JJ
        fibrosis_NNS isolates_VBZ of_IN 
        P_NN ._. aeruginosa_NN had_VBD lipid_NN A_DT isoforms_NNS
        derivatized_JJ with_IN aminoarabinose_NN (_( or_CC palmitate_NN )_) ,_, that_IN these_DT
        structural_JJ modifications_NNS could_MD enhance_VB resistance_NN to_TO
        cationic_JJ antimicrobial_NN peptides_NNS [_NN 61_CD ]_NN ._. Although_IN the_DT acyl_NN
        chains_NNS of_IN lipid_NN A_DT might_MD also_RB provide_VB alternative_NN binding_JJ
        sites_NNS for_IN protegrin_NN ,_, the_DT orientation_NN of_IN lipid_NN A_DT on_IN the_DT HPA_NNP
        sensor_NN chip_NN (_( "_'' butter-side_JJ down_RB "_'' )_) probably_RB removes_VBZ them_PRP from_IN
        consideration_NN ,_, at_IN least_JJS under_IN our_PRP$ study_NN conditions_NNS ._.
        The_DT core_NN and_CC outer_JJ polysaccharide_NN regions_NNS of_IN LPS_NNP should_MD
        provide_VB additional_JJ binding_JJ sites_NNS ,_, including_VBG the_DT carboxylate_NN
        moieties_NNS of_IN KDO_NNP or_CC KO_NNP
        (_( D-_NNP glycero-_NN D-_NNP talo-oct-_JJ 2_CD -_: ulopyranosylonic_JJ acid_NN [_NN 62_CD ]_NN ._. This_DT
        could_MD explain_VB why_WRB 
        B_NNP ._. cepacia_NN LPS_NNP binds_NNS about_IN as_IN much_JJ
        PG-_NNP 1_CD as_IN 
        P_NN ._. aeruginosa_NN LPS_NNP (_( Fig_NNP ._. 5_LS )_) especially_RB
        at_IN peptide_NN concentrations_NNS of_IN 10_CD -_: 20_CD μM_NN ,_, which_WDT allow_VBP binding_JJ
        to_TO lower_JJR affinity_NN sites_NNS ._. This_DT interpretation_NN helps_VBZ explain_VB
        why_WRB Fig_NNP ._. 3_LS suggests_VBZ that_IN 
        B_NNP ._. cepacia_NN LPS_NNP binds_NNS protegrin_NN less_RBR
        effectively_RB than_IN the_DT corresponding_JJ 
        P_NN ._. aeruginosa_NN preparation_NN ,_, while_IN the_DT
        SPR_NNP results_NNS in_IN Fig_NNP ._. 5_LS show_NN that_IN 
        B_NNP ._. cepacia_NN and_CC 
        P_NN ._. aeruginosa_NN LPS_NNP bound_VBN equivalent_NN
        amounts_NNS of_IN PG-_NNP 1_CD at_IN high_JJ (_( 10_CD -_: 20_CD μM_NN )_) protegrin_NN
        concentrations_NNS ._. To_TO resolve_VB these_DT seemingly_RB discrepant_NN
        results_NNS ,_, it_PRP is_VBZ important_JJ to_TO recall_VB that_IN in_IN SPR_NNP assays_NNS ,_, the_DT
        sensor_NN chips_NNS were_VBD constantly_RB bathed_VBN with_IN a_DT fixed_VBN protegrin_NN
        concentration_NN ranging_VBG from_IN 1_CD -_: 20_CD μM_NN and_CC that_IN in_IN radial_NN
        diffusion_NN assays_NNS ,_, the_DT wells_NNS received_VBD a_DT fixed_VBN initial_JJ amount_NN
        of_IN protegrin_NN (_( 50_CD ng_NN )_) ._. In_IN the_DT latter_JJ assays_NNS ,_, the_DT peptide_NN was_VBD
        dispersed_VBD in_IN a_DT total_JJ volume_NN of_IN 10_CD μl_NN ,_, making_VBG its_PRP$ maximal_NN
        initial_JJ concentration_NN approximately_RB 2_CD ._. 3_CD μM_NN -_: well_RB below_IN the_DT
        10_CD -_: 20_CD μM_NN concentrations_NNS needed_VBN to_TO saturate_VB LPS_NNP ._. Moreover_RB ,_,
        in_IN addition_NN to_TO binding_VBG the_DT LPS_NNP or_CC lipid_NN A_DT molecules_NNS we_PRP
        added_VBD to_TO the_DT well_NN ,_, some_DT of_IN the_DT initially_RB added_VBN protegrin_NN
        could_MD diffuse_NN radially_RB into_IN the_DT underlay_NN gel_NN ._. Both_DT initial_JJ
        binding_JJ and_CC radial_NN diffusion_NN will_MD decrease_VB the_DT
        concentration_NN of_IN free_JJ (_( i_NNP ._. e_SYM ._. ,_, unbound_NN )_) protegrin_NN that_WDT
        remains_VBZ in_IN the_DT well_NN ,_, and_CC further_JJ skew_NN its_PRP$ binding_JJ towards_IN
        higher_JJR affinity_NN binding_JJ sites_NNS on_IN lipid_NN A_DT ._.
        Although_IN our_PRP$ data_NNS clearly_RB establish_VB the_DT presence_NN of_IN a_DT
        reduced_VBN number_NN of_IN binding_JJ sites_NNS for_IN protegrin_NN in_IN lipid_NN A_DT
        from_IN 
        B_NNP ._. cepacia_NN ,_, as_IN compared_VBN to_TO lipid_NN A_DT
        from_IN 
        P_NN ._. aeruginosa_NN ,_, they_PRP do_VBP not_RB identify_VB
        the_DT cause_NN of_IN this_DT phenomenon_NN ._. These_DT alterations_NNS could_MD
        result_VB from_IN 4_CD -_: aminoarabinose_NN substitutions_NNS on_IN the_DT lipid_NN A_DT ,_,
        from_IN other_JJ changes_NNS that_WDT reduce_VBP the_DT number_NN of_IN ion-binding_JJ
        sites_NNS ,_, or_CC from_IN changes_NNS that_WDT affect_VBP hydrophobic_JJ interactions_NNS
        or_CC membrane_NN insertion_NN ._. Additional_JJ studies_NNS that_DT characterize_VBP
        
        B_NNP ._. cepacia_NN LPS_NNP and_CC lipid_NN A_DT can_MD help_VB
        pinpoint_VB the_DT exact_JJ structural_JJ differences_NNS that_WDT relate_VBP to_TO
        the_DT relative_JJ resistance_NN of_IN 
        B_NNP ._. cepacia_NN to_TO protegrins_NNS and_CC to_TO
        endogenous_JJ antimicrobial_NN peptides_NNS of_IN humans_NNS ._.
      
      
        Conclusion_NNP
        Our_PRP$ studies_NNS demonstrate_VBP a_DT correlation_NN between_IN protegrin_NN
        sensitivity_NN /_NN resistance_NN and_CC protegrin_NN binding_JJ in_IN 
        P_NN ._. aeruginosa_NN and_CC 
        B_NNP ._. cepacia_NN ,_, and_CC support_VB a_DT hypothesis_NNS
        that_IN the_DT relative_JJ resistance_NN of_IN 
        B_NNP ._. cepacia_NN to_TO protegrin_NN is_VBZ due_JJ
        principally_RB to_TO a_DT reduced_VBN number_NN of_IN protegrin_NN binding_JJ sites_NNS
        on_IN the_DT lipid_NN A_DT moiety_NN of_IN its_PRP$ LPS_NNP ._.
      
      
        Abbreviations_NNP
        BSA_NNP =_SYM bovine_JJ serum_NN albumin_NN ;_: CF_NNP =_SYM cystic_JJ fibrosis_NNS ;_: CFTR_NNP =_SYM
        cystic_JJ fibrosis_NNS transmembrane_NN conductance_NN regulator_NN ;_: C_NNP 
        L_NNP =_SYM lethal_JJ concentration_NN ;_: DMSO_NNP =_SYM
        dimethyl_NN sulfoxide_NN ;_: EC_NNP 
        50_CD =_SYM effective_JJ concentration_NN 50_CD %_NN ;_: EDTA_NNP =_SYM
        ethylenediamine_NN tetraacetic_JJ acid_NN ;_: GGPG_NNP =_SYM modified_VBN PG-_NNP 1_CD with_IN
        a_DT glycine-rich_JJ hexapeptide_NN extension_NN (_( GGGYGG_NNP )_) containing_VBG a_DT
        single_JJ tyrosine_NN residue_NN ;_: HEPES_NNP =_SYM
        N-_NNP 2_CD -_: hydroxyethylpiperazine-_NN N-_NNP 2_CD -_: ethanesulfonic_JJ acid_NN ;_: HPLC_NNP =_SYM
        high_JJ performance_NN liquid_JJ chromatography_NN ;_: I-GGPG_NNP =_SYM
        monoiodinated_JJ variant_NN of_IN GGPG_NNP ;_: LPS_NNP =_SYM lipopolysaccharide_NN ;_:
        MAC_NNP =_SYM minimal_JJ active_JJ concentration_NN ;_: PG-_NNP 1_CD =_SYM protegrin-_NN 1_CD ;_: RU_NNP
        =_SYM resonance_NN units_NNS ;_: SDS_NNP =_SYM sodium_NN dodecyl_NN sulfate_NN ;_: SPR_NNP =_SYM
        surface_NN plasmon_NN resonance_NN ;_: TSB_NNP =_SYM trypticase_NN soy_NN broth_NN ._.
      
    
  
